KEGG enrichment analysis showed that the pharmacological effects of GQD on CRC are closely related to well-known tumor-associated pathways, including the IL-17, tumor necrosis factor (TNF), Toll-like receptor, and NF-κB signaling pathways. Here, IL17A is linked to colorectal carcinoma.